Bruce Eaton Editas Medicine, Inc. (EDIT) insider trading activity

EDIT Quotes by TradingView

Bruce Eaton is EVP, CBO AND CTO of Editas Medicine, Inc.. Currently has a direct ownership of 74,791 shares of EDIT, which is worth approximately $90,497. The most recent transaction as insider was on Dec 05, 2023, when has been sold 103 shares (Common Stock) at a price of $10.9 per share, resulting in proceeds of $1,122. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.8K
0% 3M change
0% 12M change
Total Value Held $90,497

Bruce Eaton Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 05 2023
SELL
Open market or private sale
$1,122 $10.9 p/Share
103 Reduced 0.14%
74,791 Common Stock
Nov 14 2023
SELL
Open market or private sale
$5,705 $8.21 p/Share
695 Reduced 0.92%
74,894 Common Stock
Nov 07 2023
SELL
Open market or private sale
$1,167 $8.4 p/Share
139 Reduced 0.18%
75,589 Common Stock
Sep 06 2023
SELL
Open market or private sale
$908 $8.82 p/Share
103 Reduced 0.14%
75,728 Common Stock
Aug 11 2023
SELL
Open market or private sale
$6,030 $8.59 p/Share
702 Reduced 0.92%
75,831 Common Stock
Aug 08 2023
SELL
Open market or private sale
$1,182 $8.39 p/Share
141 Reduced 0.18%
76,533 Common Stock
Jun 05 2023
SELL
Open market or private sale
$997 $9.5 p/Share
105 Reduced 0.14%
76,674 Common Stock
May 11 2023
SELL
Open market or private sale
$6,593 $9.87 p/Share
668 Reduced 0.86%
76,779 Common Stock
May 09 2023
SELL
Open market or private sale
$1,283 $9.51 p/Share
135 Reduced 0.17%
77,447 Common Stock
Mar 03 2023
SELL
Open market or private sale
$897 $8.89 p/Share
101 Reduced 0.13%
77,582 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
16,700 Added 17.69%
77,683 Common Stock
Feb 13 2023
SELL
Open market or private sale
$31,978 $9.67 p/Share
3,307 Reduced 5.14%
60,983 Common Stock
Feb 07 2023
SELL
Open market or private sale
$3,840 $11.1 p/Share
346 Reduced 0.54%
64,290 Common Stock
Dec 05 2022
SELL
Open market or private sale
$1,043 $10.23 p/Share
102 Reduced 0.16%
64,636 Common Stock
Nov 08 2022
SELL
Open market or private sale
$3,184 $11.02 p/Share
289 Reduced 0.44%
64,738 Common Stock
Sep 06 2022
SELL
Open market or private sale
$1,516 $15.01 p/Share
101 Reduced 0.16%
65,027 Common Stock
Aug 09 2022
SELL
Open market or private sale
$5,450 $18.6 p/Share
293 Reduced 0.45%
65,128 Common Stock
Jun 03 2022
SELL
Open market or private sale
$12,959 $11.54 p/Share
1,123 Reduced 1.69%
65,421 Common Stock
May 09 2022
SELL
Open market or private sale
$3,894 $13.11 p/Share
297 Reduced 0.44%
66,544 Common Stock
Apr 01 2022
SELL
Open market or private sale
$24,707 $19.64 p/Share
1,258 Reduced 1.85%
66,841 Common Stock
Mar 03 2022
SELL
Open market or private sale
$6,984 $17.33 p/Share
403 Reduced 0.59%
68,386 Common Stock
Feb 10 2022
BUY
Grant, award, or other acquisition
-
37,593 Added 35.34%
68,789 Common Stock
Feb 08 2022
SELL
Open market or private sale
$5,324 $17.63 p/Share
302 Reduced 0.96%
31,196 Common Stock
Dec 22 2021
BUY
Grant, award, or other acquisition
-
3,472 Added 9.93%
31,498 Common Stock
Nov 09 2021
SELL
Open market or private sale
$11,655 $40.61 p/Share
287 Reduced 1.01%
28,026 Common Stock
BE

Bruce Eaton

EVP, CBO AND CTO
Cambridge, MA

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EDIT